Prostaglandin biosynthesis pathway (proinflammatory) (null)

"Proinflammatory prostaglandin biosynthesis" is not a specific molecule or receptor but rather refers to the **metabolic process** by which pro-inflammatory prostaglandins are produced from arachidonic acid. This process is catalyzed primarily by the enzymes **cyclooxygenase 1 and 2** (COX‑1/PTGS1 and COX‑2/PTGS2), which convert arachidonic acid into intermediate molecules like PGG₂ and PGH₂. These intermediates are then further metabolized by various synthases into different biologically active prostanoids—including PGE₂, PGD₂, PGF₂α, thromboxanes, and prostacyclins—each with distinct physiological roles.\n\nThe **COX‑2 enzyme** is particularly important in inflammation because it is inducible by pro-inflammatory stimuli and leads to increased production of pro-inflammatory mediators like PGE₂ during tissue injury or immune activation. Drugs that inhibit this pathway—such as NSAIDs—are widely used for their anti-inflammatory effects but can have notable side effects due to interference with other physiological functions of prostaglandins.\n\nBecause "proinflammatory prostaglandin biosynthesis" describes a biochemical *pathway* rather than a discrete molecular target suitable for drug binding or biomarker measurement on its own, it should not be considered a canonical therapeutic target entity. Instead, its key components—such as **cyclooxygenase enzymes**—are the actual drug targets in clinical practice[4][8][9].\n\n> The first step in the synthesis of prostanoids is the conversion of arachidonic acid into PGH₂ by cyclooxygenase enzymes PTGS1/COX‑1 and PTGS2/COX‑2... High levels of PTGS2 can be induced in cells by pro-inflammatory stimuli... leading to increased synthesis of PGE₂ during inflammation.[1]\n\n> Cyclooxygenase inhibitors block this enzymatic activity... reducing downstream production of all major classes of pro-inflammatory eicosanoids.[8]\n\nIn summary: \n**"Proinflammatory prostaglandin biosynthesis" refers to an enzymatic metabolic process—not an individual protein target—and thus does not fit standard conventions for molecular drug targets. The correct canonical forms would be specific enzymes within this pathway such as "Cyclooxygenase 2".**\n\n---\n\nIf you need structured information about one specific enzyme within this system—for example "Cyclooxygenase 2" or "Prostaglandin E synthase"—please specify so I can provide detailed data accordingly.

Other names

Proinflammatory prostaglandin synthesisProstaglandin synthesis pathwayCyclooxygenase pathwayCOX pathway

Inhibition of cyclooxygenase enzymes to reduce prostaglandin production